TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1 Fertility Statistics - Key Countries, 2017 4.2 New Product Launch 4.3 Pipeline Analysis 4.4 Regulatory Scenario - Key Countries 4.5 Recent Industry Developments - Partnerships, Mergers & Acquisitions 5. Global Contraceptive Drugs Market Analysis, Insights and Forecast, 2014-2025 5.1. Key Findings/Summary 5.2. Market Analysis, Insights and Forecast – By Product Type 5.2.1 Oral 5.2.1.1 Combined Contraceptives 5.2.1.2 Progestin-only Pills 5.2.2 Injectable 5.2.2 Patches 5.3. Market Analysis, Insights and Forecast – By Distribution Channel 5.3.1 Hospital Pharmacy 5.3.2 Retail Pharmacy 5.3.3 Clinics 5.3.4 Online Channel 5.3.5 Public Channel & NGOs 5.3.6 Others 5.4. Market Analysis, Insights and Forecast – By Region 5.4.1 North America 5.4.2 Europe 5.4.3 Asia Pacific 5.4.4 Latin America 5.4.5 Middle East & Africa 6. North America Contraceptive Drugs Market Analysis, Insights and Forecast,2014-2025 6.1. Key Findings/ Summary 6.2. Market Analysis – By Product Type 6.2.1 Oral 6.2.1.1 Combined Contraceptives 6.2.1.2 Progestin-only Pills 6.2.2. Injectable 6.2.3 Patches 6.3. Market Analysis – By Distribution Channel 6.3.1 Hospital Pharmacy 6.3.2 Retail Pharmacy 6.3.3 Clinics 6.3.4 Online Channel 6.3.5 Public Channel & NGOs 6.3.6 Others 6.4. Market Analysis – By Country 6.4.1 U.S 6.4.2 Canada 7. Europe Contraceptive Drugs Market Analysis, Insights and Forecast, 2014-2025 7.1. Key Findings/ Summary 7.2. Market Analysis – By Product Type 7.2.1 Oral 7.2.1.1 Combined Contraceptives 7.2.1.2 Progestin-only Pills 7.2.2 Injectable 7.2.3 Patches 7.3. Market Analysis – By Distribution Channel 7.3.1 Hospital Pharmacy 7.3.2 Retail Pharmacy 7.3.3 Clinics 7.3.4 Online Channel 7.3.5 Public Channel & NGOs 7.3.6 Others 7.4. Market Analysis – By Countries/Sub regions 7.4.1 U.K 7.4.2 Germany 7.4.3 France 7.4.4 Italy 7.4.5 Spain 7.4.6 Scandinavia 7.4.7 Rest of Europe 8. Asia Pacific Contraceptive Drugs Market Analysis, Insights and Forecast,2014-2025 8.1. Key Findings/ Summary 8.2. Market Analysis – By Product Type 8.2.1 Oral 8.2.1.1 Combined Contraceptives 8.2.1.2 Progestin-only Pills 8.2.2 Injectable 8.2.3 Patches 8.3. Market Analysis – By Distribution Channel 8.3.1 Hospital Pharmacy 8.3.2 Retail Pharmacy 8.3.3 Clinics 8.3.4 Online Channel 8.3.5 Public Channel & NGOs 8.3.6 Others 8.4. Market Analysis – By Countries/Sub regions 8.4.1 Japan 8.4.2 China 8.4.3 India 8.4.4 Southeast Asia 8.4.5 Australia 8.4.6 Rest of Asia Pacific 9. Latin America Contraceptive Drugs Market Analysis, Insights and Forecast,2014-2025 9.1. Key Findings/ Summary 9.2. Market Analysis – By Product Type 9.2.1 Oral 9.2.1.1 Combined Contraceptives 9.2.1.2 Progestin-only Pills 9.2.2 Injectable 9.2.3 Patches 9.3. Market Analysis – By Distribution Channel 9.3.1 Hospital Pharmacy 9.3.2 Retail Pharmacy 9.3.3 Clinics 9.3.4 Online Channel 9.3.5 Public Channel & NGOs 9.3.6 Others 9.4. Market Analysis – By Countries/Sub regions 9.4.1 Brazil 9.4.2 Mexico 9.4.3 Rest of Latin America 10. Middle East & Africa Contraceptive Drugs Market Analysis, Insights and Forecast, 2014-2025 10.1. Key Findings/Summary 10.2. Market Analysis – By Product Type 10.2.1 Oral 10.2.1.1 Combined Contraceptives 10.2.1.2 Progestin-only Pills 10.2.2 Injectable 10.2.3 Patches 10.3. Market Analysis – By Distribution Channel 10.3.1 Hospital Pharmacy 10.3.2 Retail Pharmacy 10.3.3 Clinics 10.3.4 Online Channel 10.3.5 Public Channel & NGOs 10.3.6 Others 10.4. Market Analysis – By Countries/Sub regions 10.4.1 South Africa 10.4.2 GCC 10.4.3 Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2017) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 11.5.1 Bayer AG 11.5.2 Pfizer Inc. 11.5.3 Janssen Global Services, LLC 11.5.4 Teva Pharmaceutical Industries Ltd. 11.5.5 Merck & Co., Inc. 11.5.6 Mylan N.V. 11.5.7 Allergan 11.5.8 HLL Lifecare Limited 11.5.9 Piramal Enterprises Ltd. 11.5.10 Other Prominent Players 12. Strategic Recommendations

Bayer AG Pfizer Inc. Janssen Global Services, LLC Teva Pharmaceutical Industries Ltd. Merck & Co., Inc. Mylan N.V. Allergan Plc Agile Therapeutics Piramal Enterprises Ltd.